Age, male sex, body mass index <22, diabetes in insulin therapy, prior symptomatic stroke, prior history of atrial fibrillation, dialysis, anemia, malignancy currently under treatment, LVEF below 68%, and the initial AVR strategy were associated with non-cardiac mortality (Table 1). This evidence concerns the gene INS and atrial fibrillation.